Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Dia-Präsentation von Merck Gesellschaft mbH.
CIBIS II - Cardiac Insufficiency Bisoprolol Study (12 Abbildungen)
Übersicht
Gesamtpräsentation zum Download (rechte Maustaste und "Ziel speichern unter..." klicken)


Abb. 0: FÜR ÖSTERREICH: Weitere Informationen: Merck Gesellschaft mbH, Zimbagasse 5, 1147 Wien, Tel.: 01/576 00-0 Aktuelles Bild - Abb. 1: CIBIS II - Cardiac Insufficiency Bisoprolol Study Abb. 2: CIBIS II - Cardiac Insufficiency Bisoprolol Study - Objectives Abb. 3: CIBIS II - Cardiac Insufficiency Bisoprolol Study - Main inclusion criteria Abb. 4: CIBIS II - Cardiac Insufficiency Bisoprolol Study - Design Abb. 5: CIBIS II - Cardiac Insufficiency Bisoprolol Study - Characteristics (I) Abb. 6: CIBIS II - Cardiac Insufficiency Bisoprolol Study - Characteristics (II) Zum letzten Bild
Abbildung 1: CIBIS II - Cardiac Insufficiency Bisoprolol Study
Bisoprolol fumarate (2:1) is a racemate and as a derivative of phenoxyaminopropa-nol it belongs to the class of therapeutic substances known as ß-blockers. Bisoprolol fumarate is very freely soluble in water and freely soluble in ethanol and chloroform. The molecular weight is 383.48, the white crystalline substance melts at 101°C.
 
CIBIS II - Cardiac Insufficiency Bisoprolol Study
Vorheriges Bild Nächstes Bild   


Abbildung 1: CIBIS II - Cardiac Insufficiency Bisoprolol Study
Bisoprolol fumarate (2:1) is a racemate and as a derivative of phenoxyaminopropa-nol it belongs to the class of therapeutic substances known as ß-blockers. Bisoprolol fumarate is very freely soluble in water and freely soluble in ethanol and chloroform. The molecular weight is 383.48, the white crystalline substance melts at 101°C.
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung